Perform a patch test on a small area of skin (inner wrist or behind the ear) 24 hours before first full application
Consulte a un profesional de salud si presenta glucosa en ayunas 126 mg/dL, A1C 6.5%, o sntomas de hiperglucemia persistente.
Inspect for clarity
Level of evidence Glycemic control during pregnancy has been reported to reduce the risk of perinatal complications, as evidenced by RCTs in pregnant women with T1DM and observational studies in other pregnant women

Cignas typical PA requirements for Wegovy include: BMI documentation Documented BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea Comorbidity documentation If your BMI is between 27 and 30, your clinician must provide clinical evidence of at least one qualifying comorbidity and explain why weight reduction would improve that condition Clinical evaluation Documentation of a thorough clinical evaluation, including weight history, prior weight management attempts, and current health status Prescriber qualifications The prescriber must have appropriate authority and, in some plans, must be a specialist or part of a weight management program Prior authorization is a documentation requirement, not a denial